Home/Prokarium/Dara Henry, PhD
DH

Dara Henry, PhD

Chief Operating Officer

Prokarium

Therapeutic Areas

Prokarium Pipeline

DrugIndicationPhase
ZH9Non-Muscle Invasive Bladder Cancer (NMIBC)Phase 1
ZH9 + Checkpoint InhibitorsMuscle-Invasive Bladder Cancer (MIBC)Discovery/Preclinical
IO PrimeImmunotherapy Prime (Indication Agnostic)Preclinical/IND-enabling
Living Cures PlatformVarious Cancers (Cargo Delivery)Discovery